Low-Dose Nivolumab Shows Responses in Retrospective Nepal Cancer Cohort
A retrospective Nepalese cohort of 31 patients associated 20- or 40-milligram nivolumab with responses across advanced cancers, but uncontrolled evidence ...
A retrospective Nepalese cohort of 31 patients associated 20- or 40-milligram nivolumab with responses across advanced cancers, but uncontrolled evidence ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine